The number appears most prominently as a regulatory and scientific identifier, particularly within the medical and physical sciences. Pharmaceutical Identifier (BLA 125031)
Recent supplemental applications (e.g., BLA 125031/S-0202) have added critical safety information to the drug's labeling, including increased risks of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) when used alongside chemotherapy or radiation for breast and lung cancer. Scientific Literature Identifier 125031
Is there a —such as medicine, physics, or data tracking—you were looking for information on? The number appears most prominently as a regulatory